Bacteroides uniformis RYC3373 resistant to 64 ,ug of chloramphenicol per ml was isolated from a peritoneal pelvic abscess of a patient not previously treated with this drug. Chloramphenicol resistance was transferable at low frequency to a suitable Bacteroides fragiis recipient. The acquisition of resistance was linked to the presence of a 39.5-kilobase plasmid (pRYC3373), which was subsequently transferred to a secondary recipient.
At present, one of the limited uses of chloramphenicol (Cm) is the treatment of some serious infections caused by organisms of the Bacteroides fragilis group (6, 18) . In susceptibility studies, Cm resistance proved to be very rare in this group of organisms (6) , although clinical failures have been described (21) .
Cm resistance in most pathogenic bacteria is plasmid borne and due to the presence of an enzyme, chloramphenicol acetyltransferase (CAT), which catalyzes the acetyl coenzyme A-dependent acetylation of the antibiotic (23 (4) . The enzyme was apparently similar to the CAT type II from enterobacteria, encoded by several conjugative plasmids (23) . However, the genetic basis of CAT synthesis in Bacteroides spp. has not been established.
To date, all plasmids studied in Bacteroides spp. confer clindamycin resistance (7, 12, 24, 26, 27) . All are selftransmissible, and their conjugative host range seems to be limited to the B. fragilis group. Nevertheless, intra-and intergeneric transfers of Cm resistance among strains of the B. fragilis group and from Bacteroides spp. to E. coli, respectively, have been described, but neither the plasmids nor the resistance mechanisms were investigated (14, 20) .
In this study, we report isolation of a transferable plasmid associated with resistance to Cm in a clinical isolate of B. uniformis as well as comparison of the CAT involved in the resistance with previously described enzymes from E. coli and B. fragilis.
(Part of this work was presented in the 4th Mediterranean Congress of Chemotherapy, Rhodos, Greece, 1984) .
MATERIALS AND METHODS
Bacterial strains and plasmids. The Cm-resistant strain, B. uniformis RYC3373, was isolated in 1983 from a clinical sample. As primary recipient strain, B. fragilis RYC6220 was used; this was a spontaneous rifampin-resistant derivative of a clinical isolate susceptible to Cm, clindamycin, ampicillin, and tetracycline. In secondary matings, we used B. fragilis * Media and culture conditions. The solid media used were brain heart infusion agar for the growth of E. coli, and brucella blood-supplemented agar for Bacteroides spp. The liquid medium was brain heart infusion broth for E. coli and brain heart infusion broth supplemented with 0.0005% hemin, 0.05% L-cysteine, and 0.5% yeast extract (8) for Bacteroides spp. Anaerobic chamber and GasPak jars (BBL Microbiology Systems) were used for culturing anaerobes, and a rotary shaker was used for liquid cultures of E. coli. All strains were incubated at 37°C.
Determination of MICs. MIC determinations for anaerobes were performed by the standard agar dilution method on Wilkins-Chalgren agar (25) . The corresponding agar dilution method was used for E. coli (2) on brain heart infusion agar plates. The inducibility of antibiotic resistance was evaluated by comparing MICs determined before and after the strain was grown in liquid medium with drug concentrations ranging from 0.1 ,ug/ml to one-half the MIC.
Plasmid transfer procedure. Matings between Bacteroides spp. were carried out for 16 h on membrane filters (type HA; pore size, 0.45 ,m; Millipore Corp.) as described by Macrina et al. (11) . Transconjugant selection was made on agar plates containing Cm (16 pug/ml), clindamycin (16 ,ug/ml), ampicillin (16 ,ug/ml), or tetracycline (2 pg/ml), plus the counterselective drug (rifampin at 32 ,ug/ml or fusidic acid at 16 ,ug/ml).
Transfer frequencies were calculated by dividing the number of drug-resistant transconjugants by the number of input donor cells. Transconjugants were reisolated on selective media and examined for an unselected phenotypic trait. Primary transconjugants were indole negative like the recipient strain, whereas B. uniformis is indole positive. In secondary crosses, the progeny were similar to the B. fragilis 638 fs parent in susceptibility to rifampin.
Bioassay of Cm inactivation. As a presumptive test for (23); in the case of the CAT encoded by pRYC3373, there was no cross-resistance between Cm and fusidic acid.
detecting Cm enzymatic inactivation, a susceptible Bacteroides strain was seeded on an agar plate, and a standard Cm 30-,ug disk was placed in its center. Resistant strains and appropriate controls were streaked radially, and the presence of a clover-leaf-type distortion of the zone of inhibition around the resistant strain was evaluated after 24 h of incubation.
Preparation and assay of CAT. Cells from 40-ml lateexponential-phase culture were harvested by centrifugation and suspended in 2 ml of 50 mM Tris-hydrochloride (pH 7.8) containing 50 p,M 2-mercaptoethanol. Cells were sonically disrupted with a Sonicator 200 W for 2 min at 4°C and the crude cell extract was obtained after high-speed centrifugation (30,000 x g, 20 min, 4°C) and used for the assay of CAT by the spectrophotometric method (22) . A unit of enzyme was expressed as micromoles of coenzyme A-sulfhydryl liberated per minute, and specific activity was expressed as micromoles per milligram of protein per minute. Protein concentrations were determined by the method of Lowry et al. (10) .
Michaelis constants (Kin) for Cm were determined by measuring the reaction velocities for incubation mixtures containing a range of Cm concentrations from 0.005 to 0.1 mM.
Inhibition of CAT by DTNB. The crude cell extracts were tested for sensitivity to 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), a reagent which modifies reactive thiol groups, by the method of Roberts et al. (19) . The extracts were incubated at 37°C with 1 mM DTNB, and samples were removed at 0, 7, 15, and 30 min and assayed for enzyme activity.
DNA analysis. Lysates of parental and transconjugant cells were prepared by a rapid alkaline-lysis method recommended for the detection of high-molecular-weight plasmids (5) and then subjected to agarose gel electrophoresis. Purified DNA was obtained by cesium chloride-ethidium bromide density gradient ultracentrifugation (5) of lysates obtained with sodium dodecyl sulfate from prestationary 300-ml cultures (5 (8) including gas-liquid chromatography. The strain was susceptible to metronidazole (MIC = 0.5 ,ug/ml) and cefoxitin (MIC = 8 jig/ml) but was resistant to Cm (MIC = 128 ,ug/ml) and clindamycin (MIC > 128 ,ug/ml), erythromycin (MIC > 128 ,ug/ml), spiramycin (MIC > 128 jig/ml), and tylosin (MIC = 64 ,ug/ml) (MLS antibiotics). The strain was also a strong ,-lactamase producer (data not shown) with an ampicillin MIC of >128 ,ug/ml and showed inducible tetracycline resistance (17) with MICs increasing from 4 to 32 p.g/ml after growth in the presence of subinhibitory concentrations of this drug.
Cm resistance appeared to be of the constitutive type, as no changes in MIC were observed when the strain was previously grown with Cm at different subinhibitory concentrations.
Antibiotic resistance transfer. Table 1 summarizes the results of the drug resistance transfer. It appears that the B. uniformis strain contained at least four resistance determinants capable of being transferred independently. Nevertheless, the frequency with which several determinants were found in the transconjugants indicates the cotransfer of some resistance markers. It is noteworthy that transfer of the tetracycline resistance determinant could only be detected after preexposure of the donor to tetracycline. Premating treatment with Cm, ampicillin, or clindamycin did not affect the transfer frequency of any resistance determinant. Transconjugant strain B. fragilis RYC6300-1, which received only the Cm resistance determinant at an approximate frequency of 10-7, was (24) . Nevertheless, Cm resistance can be associated with this plasmid because in Cmsusceptible but clindamycin-, ampicillin-, or tetracyclineresistant transconjugants, no plasmid DNA was detected.
The plasmid of the transconjugant B. fragilis RYC6302-1 was isolated by dye-buoyant density gradient ultracentrifugation. The estimated size of this plasmid, named pRYC3373, was 39.5 kilobase pairs (23.7 megadaltons), based on the sum of the four AccI restriction fragments (Fig.  1) .
Biochemical basis of Cm resistance. When Cm inactivation was tested on solid medium by bioassay, it was found that wild-type and transconjugant Cm-resistant Bacteroides strains gave a strongly positive result. Crude extracts of sonicated cultures were then submitted to specific spectrophotometric CAT assay. High levels of nonspecific thiosterase activity were detected by the formation of coenzyme A-sulfhydryl in the absence of Cm in both susceptible and resistant Bacteroides strains as previously described (4). After cell extracts were heated at 70°C for 10 min (4), a 90% reduction in thiosterase activity was observed, and specific CAT activity was only detected in Cm-resistant strains.
Properties of CAT from B. uniformis RYC3373. The inactivating enzyme encoded by plasmid pRYC3373 in Bacteroides spp. was not released into the surrounding medium, as no activity could be detected in the supernatant obtained after centrifugation of liquid cultures of Cm-resistant strains. The enzyme was constitutively synthesized, as growth in subinhibitory concentrations of Cm did not increase the enzymatic activity significantly.
The specific activity of B. uniformis CAT was 0.5 ,umol/min per mg of protein, in crude extracts of both the donor and transconjugant resistant strains. The activity of B. fragilis F47 and F48 enzyme (4) was ca. 10-fold lower. The Cm MIC was 128 ,ug/ml for pRYC3373-bearing strains, whereas that for B. fragilis F47 and F48 was 12.5 ,ug/ml (4 Bacteroides spp. (7, 11, 13) ; clindamycin resistance genes homologous to the plasmid resistance genes appeared to be located in the chromosome of many different Bacteroides * isolates (7, 11, 13) . The same location is suggested for transferable tetracycline resistance (11, 13) . Until (Fig. 2) . The resistance mechanism has been described in some strains of :yme has also been described as susceptible to B. fragilis which exhibit Cm susceptibility in conventional y DTNB (4 tetracycline.
Only plasmid pIP410 (12) , also known as pBF4 (27) , and plasmid pBFTM10 (26) , and, more recently, plasmids pBI136 (24) and pCP1 (7) 
